May 25th, 2008 at 9:49 am
Alcoholism: Clinical and Experimental Research, Volume 0, Issue 0, Page ???, OnlineEarly Articles.
Background: Access to specialty alcoholism treatment in rural environments is limited and new treatment approaches are needed. The objective was to evaluate the efficacy of naltrexone alone and in combination with sertraline among Alaska Natives and other … (Source: Alcoholism: Clinical and Experimental Research)
Please take a moment to comment, write a post,or subscribe to our RSS feed!
May 22nd, 2008 at 9:49 am
Researchers from the Howard Florey Institute in Melbourne have identified a factor that may contribute towards the development of heroin addiction by manipulating the adenosine A2A receptor, which plays a major role in the brain’s ‘reward pathway’.Using mice specifically bred without the adenosine A2A receptor, Prof Andrew Lawrence and his team showed that these mice had a reduced desire to self-administer morphine; heroin is converted to morphine in the body.
Please take a moment to comment, write a post,or subscribe to our RSS feed!
March 20th, 2008 at 12:59 am
Two researchers at the Baylor College of Medicine in Houston, Texas have been testing a vaccine for cocaine addiction. The new cocaine vaccine uses antibodies that attach to the drug and prohibit the cocaine from passing the blood-brain barrier.
Because the cocaine cannot be absorbed and passed to the brain tissue no high is experienced by the addict.
Dr. Tom Kosten and his wife, Therese, a psychologist and neuroscientist respectively have been working on the cocaine vaccine for the past 10 years. If approved by the FDA, the vaccine is expected to be used in conjunction with other cognitive and behavioral therapies.
Please take a moment to comment, write a post,or subscribe to our RSS feed!
